{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T19:17:16Z","timestamp":1777317436596,"version":"3.51.4"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Project funding for the training of high level health professionals in Changzhou","award":["2022CZZY007"],"award-info":[{"award-number":["2022CZZY007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To explore the use of genomic screening for congenital adrenal hyperplasia (CAH) based on long-read sequencing (LRS), aiming to provide an effective method for LRS-based screening (LRSBCS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      All newborns underwent traditional CAH screening via the collection of dried blood spots. We conducted a retrospective clinical study of 73 cases, including 12 confirmed cases of CAH, 18 cases with false-positive biochemical screening results, and 43 healthy newborns as control. Full-length CAH-related genes, including\n                      <jats:italic>CYP21A2<\/jats:italic>\n                      ,\n                      <jats:italic>CYP11B1<\/jats:italic>\n                      ,\n                      <jats:italic>CYP17A1<\/jats:italic>\n                      ,\n                      <jats:italic>HSD3B2<\/jats:italic>\n                      , and\n                      <jats:italic>STAR<\/jats:italic>\n                      were amplified and sequenced on a Sequel II platform (Pacific Biosciences).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among the 235,999 newborns, 12 were confirmed to have CAH, based on biochemical and\/or genetic testing. The positive-predictive values of the initial and positive recall results were 0.60% (12\/1958) and 3.68% (12\/326), respectively. The 12 children with CAH were accurately diagnosed using LRSBCS. For LRS, the Bayesian-estimated sensitivity is 96.2% (95% CrI: 80.3%\u201399.9%) and the specificity is 99.2% (95% CrI: 98.0%\u201399.9%). Eleven pathogenic variants of\n                      <jats:italic>CYP21A2<\/jats:italic>\n                      were detected, including eight SNVs\/indels and three deletions. The most frequent variants were c.293\u201313\u00a0C\u2009&gt;\u2009G (7\/11) and c.518T\u2009&gt;\u2009A (7\/11). Furthermore, LRSBCS can directly report the characteristics of gene variants (cis or trans mutations) and effectively distinguish between functional genes and pseudogenes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>LRSBCS represents a novel molecular screening approach tailored specifically for CAH, demonstrating preliminary feasibility in clinical settings.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical trial number<\/jats:title>\n                    <jats:p>Not applicable.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13023-025-04116-1","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T15:35:07Z","timestamp":1763739307000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Newborn genetic screening of congenital adrenal hyperplasia using long-read sequencing"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7619-9541","authenticated-orcid":false,"given":"Yuqi","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4931-0299","authenticated-orcid":false,"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1627-8408","authenticated-orcid":false,"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7796-7314","authenticated-orcid":false,"given":"Bin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"issue":"10372","key":"4116_CR1","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0140-6736(22)01330-7","volume":"401","author":"MK Auer","year":"2023","unstructured":"Auer MK, Nordenstr\u00f6m A, Lajic S, Reisch N. Congenital adrenal hyperplasia. Lancet (London England). 2023;401(10372):227\u201344.","journal-title":"Lancet (London England)"},{"issue":"9","key":"4116_CR2","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.3390\/jcm12093128","volume":"12","author":"T Uslar","year":"2023","unstructured":"Uslar T, Olmos R, Mart\u00ednez-Aguayo A, Baudrand R. Clinical update on congenital adrenal hyperplasia: recommendations from a multidisciplinary adrenal program. J Clin Med. 2023;12(9):3128.","journal-title":"J Clin Med"},{"issue":"1","key":"4116_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1210\/er.2010-0013","volume":"32","author":"WL Miller","year":"2011","unstructured":"Miller WL, Auchus RJ. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev. 2011;32(1):81\u2013151.","journal-title":"Endocr Rev"},{"issue":"2","key":"4116_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.beem.2008.10.014","volume":"23","author":"N Krone","year":"2009","unstructured":"Krone N, Arlt W. Genetics of congenital adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab. 2009;23(2):181\u201392.","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"1","key":"4116_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1159\/000522230","volume":"95","author":"M Lind-Holst","year":"2022","unstructured":"Lind-Holst M, B\u00e6kvad-Hansen M, Berglund A, Cohen AS, Melgaard L, Skogstrand K, et al. Neonatal screening for congenital adrenal hyperplasia in denmark: 10 years of experience. Hormone Res Paediatrics. 2022;95(1):35\u201342.","journal-title":"Hormone Res Paediatrics"},{"issue":"4","key":"4116_CR6","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3390\/ijns8040056","volume":"8","author":"MR de Hora","year":"2022","unstructured":"de Hora MR, Heather NL, Webster DR, Albert BB, Hofman PL. Evaluation of a new laboratory protocol for newborn screening for congenital adrenal hyperplasia in new Zealand. Int J Neonatal Screen. 2022;8(4):56.","journal-title":"Int J Neonatal Screen"},{"issue":"9","key":"4116_CR7","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nrendo.2009.148","volume":"5","author":"PC White","year":"2009","unstructured":"White PC. Neonatal screening for congenital adrenal hyperplasia. Nat Reviews Endocrinol. 2009;5(9):490\u20138.","journal-title":"Nat Reviews Endocrinol"},{"issue":"1","key":"4116_CR8","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12887-016-0772-x","volume":"17","author":"C Kopacek","year":"2017","unstructured":"Kopacek C, de Castro SM, Prado MJ, da Silva CM, Beltr\u00e3o LA, Spritzer PM. Neonatal screening for congenital adrenal hyperplasia in Southern brazil: a population based study with 108,409 infants. BMC Pediatr. 2017;17(1):22.","journal-title":"BMC Pediatr"},{"issue":"11","key":"4116_CR9","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1515\/jpem-2019-0140","volume":"32","author":"X Jiang","year":"2019","unstructured":"Jiang X, Tang F, Feng Y, Li B, Jia X, Tang C, et al. The adjustment of 17-hydroxyprogesterone cut-off values for congenital adrenal hyperplasia neonatal screening by GSP according to gestational age and age at sampling. J Pediatr Endocrinol Metab. 2019;32(11):1253\u20138.","journal-title":"J Pediatr Endocrinol Metab"},{"issue":"1","key":"4116_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.3390\/ijns6010006","volume":"6","author":"MR de Hora","year":"2020","unstructured":"de Hora MR, Heather NL, Patel T, Bresnahan LG, Webster D, Hofman PL. Measurement of 17-Hydroxyprogesterone by LCMSMS improves newborn screening for CAH due to 21-Hydroxylase deficiency in new Zealand. Int J Neonatal Screen. 2020;6(1):6.","journal-title":"Int J Neonatal Screen"},{"issue":"3","key":"4116_CR11","doi-asserted-by":"publisher","first-page":"36","DOI":"10.3390\/ijns7030036","volume":"7","author":"A Tsuji-Hosokawa","year":"2021","unstructured":"Tsuji-Hosokawa A, Kashimada K. Thirty-Year lessons from the newborn screening for congenital adrenal hyperplasia (CAH) in Japan. Int J Neonatal Screen. 2021;7(3):36.","journal-title":"Int J Neonatal Screen"},{"issue":"1","key":"4116_CR12","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3390\/ijns9010009","volume":"9","author":"J Tippabathani","year":"2023","unstructured":"Tippabathani J, Seenappa V, Murugan A, Phani NM, Hampe MH, Appaswamy G, et al. Neonatal screening for congenital adrenal hyperplasia in Indian newborns with reflex genetic analysis of 21-Hydroxylase deficiency. Int J Neonatal Screen. 2023;9(1):9.","journal-title":"Int J Neonatal Screen"},{"issue":"1","key":"4116_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jgg.2021.08.008","volume":"49","author":"C Hao","year":"2022","unstructured":"Hao C, Guo R, Hu X, Qi Z, Guo Q, Liu X, et al. Newborn screening with targeted sequencing: a multicenter investigation and a pilot clinical study in China. J Genet Genomics. 2022;49(1):13\u20139.","journal-title":"J Genet Genomics"},{"issue":"3","key":"4116_CR14","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41436-018-0105-6","volume":"21","author":"CA Genetti","year":"2019","unstructured":"Genetti CA, Schwartz TS, Robinson JO, VanNoy GE, Petersen D, Pereira S, et al. Parental interest in genomic sequencing of newborns: enrollment experience from the babyseq project. Genet Med. 2019;21(3):622\u201330.","journal-title":"Genet Med"},{"issue":"9","key":"4116_CR15","doi-asserted-by":"publisher","first-page":"1392","DOI":"10.1038\/s41591-020-0966-5","volume":"26","author":"AN Adhikari","year":"2020","unstructured":"Adhikari AN, Gallagher RC, Wang Y, Currier RJ, Amatuni G, Bassaganyas L, et al. The role of exome sequencing in newborn screening for inborn errors of metabolism. Nat Med. 2020;26(9):1392\u20137.","journal-title":"Nat Med"},{"issue":"4","key":"4116_CR16","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.ajhg.2020.08.001","volume":"107","author":"TS Roman","year":"2020","unstructured":"Roman TS, Crowley SB, Roche MI, Foreman AKM, O\u2019Daniel JM, Seifert BA, et al. Genomic sequencing for newborn screening: results of the NC NEXUS project. Am J Hum Genet. 2020;107(4):596\u2013611.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"4116_CR17","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/S2213-2600(15)00139-3","volume":"3","author":"LK Willig","year":"2015","unstructured":"Willig LK, Petrikin JE, Smith LD, Saunders CJ, Thiffault I, Miller NA, et al. Whole-genome sequencing for identification of Mendelian disorders in critically ill infants: a retrospective analysis of diagnostic and clinical findings. Lancet Respiratory Med. 2015;3(5):377\u201387.","journal-title":"Lancet Respiratory Med"},{"issue":"1","key":"4116_CR18","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1186\/s13023-021-02116-5","volume":"16","author":"H Wang","year":"2021","unstructured":"Wang H, Yang Y, Zhou L, Wang Y, Long W, Yu B. NeoSeq: a new method of genomic sequencing for newborn screening. Orphanet J Rare Dis. 2021;16(1):481.","journal-title":"Orphanet J Rare Dis"},{"key":"4116_CR19","doi-asserted-by":"publisher","first-page":"105899","DOI":"10.1016\/j.jsbmb.2021.105899","volume":"211","author":"W Wang","year":"2021","unstructured":"Wang W, Han R, Yang Z, Zheng S, Li H, Wan Z, et al. Targeted gene panel sequencing for molecular diagnosis of congenital adrenal hyperplasia. J Steroid Biochem Mol Biol. 2021;211:105899.","journal-title":"J Steroid Biochem Mol Biol"},{"issue":"7","key":"4116_CR20","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1093\/clinchem\/hvac046","volume":"68","author":"Y Liu","year":"2022","unstructured":"Liu Y, Chen M, Liu J, Mao A, Teng Y, Yan H, et al. Comprehensive analysis of congenital adrenal hyperplasia using Long-Read sequencing. Clin Chem. 2022;68(7):927\u201339.","journal-title":"Clin Chem"},{"key":"4116_CR21","doi-asserted-by":"publisher","first-page":"117419","DOI":"10.1016\/j.cca.2023.117419","volume":"547","author":"H Li","year":"2023","unstructured":"Li H, Zhu X, Yang Y, Wang W, Mao A, Li J, et al. Long-read sequencing: an effective method for genetic analysis of CYP21A2 variation in congenital adrenal hyperplasia. Clin Chim Acta. 2023;547:117419.","journal-title":"Clin Chim Acta"},{"key":"4116_CR22","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3389\/fgene.2019.00086","volume":"10","author":"Y Yuqi","year":"2019","unstructured":"Yuqi Y, Leilei W, Benjing W, shuang L, Bin Y, Ting W. Application of Next-Generation sequencing following tandem mass spectrometry to expand newborn screening for inborn errors of metabolism: A multicenter study. Front Genet. 2019;10:86.","journal-title":"Front Genet"},{"issue":"9","key":"4116_CR23","first-page":"679","volume":"54","author":"RF Wang","year":"2016","unstructured":"Wang RF, Gu XF, Ye J, Han LS, Qiu WJ, Zhang HW, et al. [Analysis of phenotypes and genotypes in 66 patients with 21-hydroxylase deficiency identified by neonatal screening]. Zhonghua Er Ke Za Zhi. 2016;54(9):679\u201385.","journal-title":"Zhonghua Er Ke Za Zhi"},{"issue":"5","key":"4116_CR24","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17(5):405\u201324.","journal-title":"Genet Med"},{"issue":"10","key":"4116_CR25","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1038\/s41431-020-0653-5","volume":"28","author":"S Baumgartner-Parzer","year":"2020","unstructured":"Baumgartner-Parzer S, Witsch-Baumgartner M, Hoeppner W. EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency. Eur J Hum Genet. 2020;28(10):1341\u201367.","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"4116_CR26","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S2213-8587(13)70007-X","volume":"1","author":"S Gidl\u00f6f","year":"2013","unstructured":"Gidl\u00f6f S, Falhammar H, Thil\u00e9n A, von D\u00f6beln U, Ritz\u00e9n M, Wedell A, et al. One hundred years of congenital adrenal hyperplasia in sweden: a retrospective, population-based cohort study. Lancet Diabetes Endocrinol. 2013;1(1):35\u201342.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"4116_CR27","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.1007\/s11033-019-04809-4","volume":"46","author":"A Dundar","year":"2019","unstructured":"Dundar A, Bayramov R, Onal MG, Akkus M, Dogan ME, Kenanoglu S, et al. The molecular basis and genotype-phenotype correlations of congenital adrenal hyperplasia (CAH) in Anatolian population. Mol Biol Rep. 2019;46(4):3677\u201390.","journal-title":"Mol Biol Rep"},{"issue":"8","key":"4116_CR28","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1210\/jc.2018-02468","volume":"104","author":"N Pode-Shakked","year":"2019","unstructured":"Pode-Shakked N, Blau A, Pode-Shakked B, Tiosano D, Weintrob N, Eyal O, et al. Combined gestational Age- and birth Weight-Adjusted cutoffs for newborn screening of congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2019;104(8):3172\u201380.","journal-title":"J Clin Endocrinol Metab"},{"issue":"19","key":"4116_CR29","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1001\/jama.290.19.2564","volume":"290","author":"SE Waisbren","year":"2003","unstructured":"Waisbren SE, Albers S, Amato S, Ampola M, Brewster TG, Demmer L, et al. Effect of expanded newborn screening for biochemical genetic disorders on child outcomes and parental stress. JAMA. 2003;290(19):2564\u201372.","journal-title":"JAMA"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04116-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-04116-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-04116-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T15:35:08Z","timestamp":1763739308000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-04116-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4116"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-04116-1","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"5 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study design and protocol were reviewed and approved by the ethics committee of Changzhou Maternal and Child Health Care Hospital (Project ID: 2023[3]).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The newborns\u2019 parents had written informed consent to publish this information.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None declared. The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"599"}}